

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.44465157 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.44465157 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.02293768 |
| 4 | protein maturation by protein folding (GO:0022417) | 4.93591571 |
| 5 | skin morphogenesis (GO:0043589) | 4.88178795 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.85879829 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.85879829 |
| 8 | protein retention in ER lumen (GO:0006621) | 4.83972502 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.73165342 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.73165342 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.18798965 |
| 12 | intestinal cholesterol absorption (GO:0030299) | 4.18432883 |
| 13 | protein carboxylation (GO:0018214) | 4.10626920 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.10626920 |
| 15 | COPII vesicle coating (GO:0048208) | 4.02270949 |
| 16 | signal peptide processing (GO:0006465) | 4.01355642 |
| 17 | barbed-end actin filament capping (GO:0051016) | 3.87362421 |
| 18 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.79983991 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.74853211 |
| 20 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.70831674 |
| 21 | protein localization to endosome (GO:0036010) | 3.69923418 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 3.69586972 |
| 23 | pinocytosis (GO:0006907) | 3.65876112 |
| 24 | extracellular fibril organization (GO:0043206) | 3.65849838 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 3.62802254 |
| 26 | basement membrane organization (GO:0071711) | 3.62490036 |
| 27 | cell adhesion mediated by integrin (GO:0033627) | 3.60066366 |
| 28 | tryptophan catabolic process (GO:0006569) | 3.59452895 |
| 29 | indole-containing compound catabolic process (GO:0042436) | 3.59452895 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 3.59452895 |
| 31 | cysteine metabolic process (GO:0006534) | 3.59417482 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 3.57926254 |
| 33 | tryptophan metabolic process (GO:0006568) | 3.51242660 |
| 34 | valine metabolic process (GO:0006573) | 3.44980443 |
| 35 | type B pancreatic cell proliferation (GO:0044342) | 3.44478641 |
| 36 | fibril organization (GO:0097435) | 3.41467083 |
| 37 | exocrine pancreas development (GO:0031017) | 3.41053589 |
| 38 | kynurenine metabolic process (GO:0070189) | 3.39938750 |
| 39 | glyoxylate metabolic process (GO:0046487) | 3.39696344 |
| 40 | regulation of extracellular matrix disassembly (GO:0010715) | 3.39490654 |
| 41 | regulation of fibrinolysis (GO:0051917) | 3.38080031 |
| 42 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.37823207 |
| 43 | high-density lipoprotein particle remodeling (GO:0034375) | 3.36470766 |
| 44 | complement activation, alternative pathway (GO:0006957) | 3.34794027 |
| 45 | pentose-phosphate shunt (GO:0006098) | 3.30818412 |
| 46 | bile acid biosynthetic process (GO:0006699) | 3.27712027 |
| 47 | regulation of protein activation cascade (GO:2000257) | 3.26280750 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.23986947 |
| 49 | vesicle coating (GO:0006901) | 3.18435773 |
| 50 | 4-hydroxyproline metabolic process (GO:0019471) | 3.18069229 |
| 51 | urea metabolic process (GO:0019627) | 3.16802934 |
| 52 | urea cycle (GO:0000050) | 3.16802934 |
| 53 | hyaluronan catabolic process (GO:0030214) | 3.16761672 |
| 54 | homocysteine metabolic process (GO:0050667) | 3.16137581 |
| 55 | glucose catabolic process (GO:0006007) | 3.11105421 |
| 56 | actin filament depolymerization (GO:0030042) | 3.10620816 |
| 57 | regulation of early endosome to late endosome transport (GO:2000641) | 3.10484090 |
| 58 | regulation of complement activation (GO:0030449) | 3.08530559 |
| 59 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.06981830 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 3.06634265 |
| 61 | stress fiber assembly (GO:0043149) | 3.06099976 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 3.05696968 |
| 63 | regulation of metalloenzyme activity (GO:0048552) | 3.04296219 |
| 64 | adhesion of symbiont to host (GO:0044406) | 3.01408010 |
| 65 | regulation of plasminogen activation (GO:0010755) | 3.00978311 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 3.00747152 |
| 67 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.00259976 |
| 68 | peptidyl-proline hydroxylation (GO:0019511) | 2.97399563 |
| 69 | positive regulation of extracellular matrix organization (GO:1903055) | 2.97298982 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 2.97138167 |
| 71 | acylglycerol homeostasis (GO:0055090) | 2.96994969 |
| 72 | triglyceride homeostasis (GO:0070328) | 2.96994969 |
| 73 | positive regulation of nuclease activity (GO:0032075) | 2.96468956 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 2.95523397 |
| 75 | macromolecular complex remodeling (GO:0034367) | 2.95523397 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 2.95523397 |
| 77 | reverse cholesterol transport (GO:0043691) | 2.94107210 |
| 78 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.93291124 |
| 79 | GDP-mannose metabolic process (GO:0019673) | 2.92510696 |
| 80 | nitrogen cycle metabolic process (GO:0071941) | 2.92411848 |
| 81 | aldehyde catabolic process (GO:0046185) | 2.89651333 |
| 82 | mesodermal cell differentiation (GO:0048333) | 2.89633242 |
| 83 | phospholipid efflux (GO:0033700) | 2.89265760 |
| 84 | fibrinolysis (GO:0042730) | 2.86739548 |
| 85 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.86476140 |
| 86 | cellular glucuronidation (GO:0052695) | 2.85455673 |
| 87 | protein hydroxylation (GO:0018126) | 2.84768482 |
| 88 | virion attachment to host cell (GO:0019062) | 2.84276693 |
| 89 | adhesion of symbiont to host cell (GO:0044650) | 2.84276693 |
| 90 | tyrosine metabolic process (GO:0006570) | 2.84225517 |
| 91 | acute-phase response (GO:0006953) | 2.83659026 |
| 92 | hypotonic response (GO:0006971) | 2.83502303 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 2.83327565 |
| 94 | NADPH regeneration (GO:0006740) | 2.82949979 |
| 95 | bile acid metabolic process (GO:0008206) | 2.79632791 |
| 96 | endodermal cell differentiation (GO:0035987) | 2.79469396 |
| 97 | cellular response to unfolded protein (GO:0034620) | 2.78718403 |
| 98 | epithelial cell-cell adhesion (GO:0090136) | 2.77732901 |
| 99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.77196074 |
| 100 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.76517235 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.76517235 |
| 102 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.76086656 |
| 103 | coenzyme catabolic process (GO:0009109) | 2.74973923 |
| 104 | lysine catabolic process (GO:0006554) | 2.74407746 |
| 105 | lysine metabolic process (GO:0006553) | 2.74407746 |
| 106 | cofactor catabolic process (GO:0051187) | 2.74123440 |
| 107 | regulation of cholesterol homeostasis (GO:2000188) | 2.73168133 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.72331462 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.72331462 |
| 110 | regulation of nuclease activity (GO:0032069) | 2.72042943 |
| 111 | proline biosynthetic process (GO:0006561) | 2.71734035 |
| 112 | positive regulation of osteoblast proliferation (GO:0033690) | 2.71364036 |
| 113 | amino-acid betaine metabolic process (GO:0006577) | 2.71266177 |
| 114 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.68705965 |
| 115 | muscle cell migration (GO:0014812) | 2.68131150 |
| 116 | glucuronate metabolic process (GO:0019585) | 2.67853785 |
| 117 | uronic acid metabolic process (GO:0006063) | 2.67853785 |
| 118 | platelet degranulation (GO:0002576) | 2.67209461 |
| 119 | cellular response to topologically incorrect protein (GO:0035967) | 2.66919007 |
| 120 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.66911056 |
| 121 | intestinal absorption (GO:0050892) | 2.66381841 |
| 122 | negative regulation of cholesterol transport (GO:0032375) | 2.66002636 |
| 123 | negative regulation of sterol transport (GO:0032372) | 2.66002636 |
| 124 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.65340673 |
| 125 | serine family amino acid biosynthetic process (GO:0009070) | 2.65175950 |
| 126 | membrane raft organization (GO:0031579) | 2.65168673 |
| 127 | ER-nucleus signaling pathway (GO:0006984) | 2.65060031 |
| 128 | lipoprotein metabolic process (GO:0042157) | 2.64239383 |
| 129 | indolalkylamine metabolic process (GO:0006586) | 2.63605087 |
| 130 | opsonization (GO:0008228) | 2.62058044 |
| 131 | xenobiotic catabolic process (GO:0042178) | 2.61685991 |
| 132 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.61606333 |
| 133 | positive regulation of receptor recycling (GO:0001921) | 2.61444643 |
| 134 | benzene-containing compound metabolic process (GO:0042537) | 2.61428911 |
| 135 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.59670063 |
| 136 | UV protection (GO:0009650) | 2.58648540 |
| 137 | alpha-amino acid catabolic process (GO:1901606) | 2.58616152 |
| 138 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.58560072 |
| 139 | membrane protein ectodomain proteolysis (GO:0006509) | 2.57699404 |
| 140 | serine family amino acid catabolic process (GO:0009071) | 2.57647017 |
| 141 | bile acid and bile salt transport (GO:0015721) | 2.57338165 |
| 142 | glycine metabolic process (GO:0006544) | 2.56620592 |
| 143 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.55644175 |
| 144 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.55644175 |
| 145 | protein heterotrimerization (GO:0070208) | 2.54817020 |
| 146 | endocrine pancreas development (GO:0031018) | 2.53300604 |
| 147 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.52380583 |
| 148 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.50173410 |
| 149 | cell-substrate junction assembly (GO:0007044) | 2.49946577 |
| 150 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.48969865 |
| 151 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.47875167 |
| 152 | collagen fibril organization (GO:0030199) | 2.47617681 |
| 153 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.47035500 |
| 154 | apoptotic cell clearance (GO:0043277) | 2.46233301 |
| 155 | mitotic nuclear envelope reassembly (GO:0007084) | 2.44913397 |
| 156 | nuclear envelope reassembly (GO:0031468) | 2.44913397 |
| 157 | maintenance of protein localization in organelle (GO:0072595) | 2.44776712 |
| 158 | regulation of collagen metabolic process (GO:0010712) | 2.44459888 |
| 159 | platelet aggregation (GO:0070527) | 2.43363744 |
| 160 | positive regulation of pseudopodium assembly (GO:0031274) | 2.42064489 |
| 161 | regulation of extracellular matrix organization (GO:1903053) | 2.41886810 |
| 162 | negative regulation of cell size (GO:0045792) | 2.40943232 |
| 163 | glucose 6-phosphate metabolic process (GO:0051156) | 2.39634310 |
| 164 | endocardial cushion development (GO:0003197) | 2.38176931 |
| 165 | desmosome organization (GO:0002934) | 2.36968146 |
| 166 | focal adhesion assembly (GO:0048041) | 2.36587676 |
| 167 | cell-substrate adherens junction assembly (GO:0007045) | 2.36587676 |
| 168 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.36548103 |
| 169 | embryo implantation (GO:0007566) | 2.35589889 |
| 170 | substrate-dependent cell migration (GO:0006929) | 2.35086876 |
| 171 | adherens junction assembly (GO:0034333) | 2.34567401 |
| 172 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.32949661 |
| 173 | proline metabolic process (GO:0006560) | 2.30565645 |
| 174 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.28482039 |
| 175 | glycosphingolipid catabolic process (GO:0046479) | 2.28069224 |
| 176 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.28047127 |
| 177 | collagen metabolic process (GO:0032963) | 2.27924248 |
| 178 | glycolipid catabolic process (GO:0019377) | 2.25649260 |
| 179 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.25462879 |
| 180 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.24159819 |
| 181 | cellular copper ion homeostasis (GO:0006878) | 2.23675463 |
| 182 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.22775660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.53881902 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.80241545 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.34014884 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.62698122 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.58011792 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57551243 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.52861692 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.50218512 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.68914956 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.67025084 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.43054964 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.35102617 |
| 13 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24619380 |
| 14 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.12582268 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.12245835 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.11108624 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.01970269 |
| 18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.94094346 |
| 19 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.91764146 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91434602 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.88298164 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.86909860 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82163477 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.80590299 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78896439 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78481919 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76128354 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73910231 |
| 29 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.73415174 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69783321 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67210669 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67036272 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65790328 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64167054 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63550287 |
| 36 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58176522 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.56977601 |
| 38 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52600344 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52391647 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.51762963 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49897069 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46093858 |
| 43 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.44420011 |
| 44 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42687279 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41619032 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41523167 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41425634 |
| 48 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.40725761 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39732502 |
| 50 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38538662 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37994185 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36629650 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35543788 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34763447 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34237168 |
| 56 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31985966 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31610562 |
| 58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29141327 |
| 59 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28199905 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27854204 |
| 61 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.27437058 |
| 62 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26855596 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23751279 |
| 64 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23320771 |
| 65 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23320771 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23067062 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22185133 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21773755 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21105491 |
| 70 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21064093 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20260270 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19473573 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18817132 |
| 74 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18702635 |
| 75 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18054952 |
| 76 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17105893 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16570730 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16150055 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15694655 |
| 80 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15289023 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14862227 |
| 82 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13981871 |
| 83 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13398792 |
| 84 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13213962 |
| 85 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.13184186 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12360739 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10873174 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10245074 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09510187 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08798480 |
| 91 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.06728560 |
| 92 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06533213 |
| 93 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06496784 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06252886 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03794090 |
| 96 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03709422 |
| 97 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03334764 |
| 98 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03021086 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02807419 |
| 100 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01945998 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01652461 |
| 102 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01379948 |
| 103 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00678778 |
| 104 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00174091 |
| 105 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.99617829 |
| 106 | MYB_26560356_Chip-Seq_TH2_Human | 0.99558167 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99454795 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99268939 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99261157 |
| 110 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98571859 |
| 111 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98408957 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98384708 |
| 113 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98160888 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97481116 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96144313 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96092294 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95970989 |
| 118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95941223 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 0.95801800 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95717211 |
| 121 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95272922 |
| 122 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.95245844 |
| 123 | MYC_22102868_ChIP-Seq_BL_Human | 0.95221993 |
| 124 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.94938673 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.93923091 |
| 126 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93462693 |
| 127 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93089969 |
| 128 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92993744 |
| 129 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92811540 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92778869 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92404078 |
| 132 | MAF_26560356_Chip-Seq_TH1_Human | 0.92264442 |
| 133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91546515 |
| 134 | MYB_26560356_Chip-Seq_TH1_Human | 0.91169273 |
| 135 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91042480 |
| 136 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.90999350 |
| 137 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90794818 |
| 138 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.90719902 |
| 139 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90526413 |
| 140 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90484438 |
| 141 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.89686970 |
| 142 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89533195 |
| 143 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88269482 |
| 144 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87939674 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85609678 |
| 146 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.85507499 |
| 147 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.85040637 |
| 148 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84835265 |
| 149 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83823666 |
| 150 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83166976 |
| 151 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83032965 |
| 152 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.82459337 |
| 153 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81729235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.82417759 |
| 2 | MP0005365_abnormal_bile_salt | 4.13625866 |
| 3 | MP0005360_urolithiasis | 3.79886058 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.48427896 |
| 5 | MP0005083_abnormal_biliary_tract | 2.90137585 |
| 6 | MP0004272_abnormal_basement_membrane | 2.82602792 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.69396331 |
| 8 | MP0003195_calcinosis | 2.68205831 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.65635654 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.59699661 |
| 11 | MP0003252_abnormal_bile_duct | 2.49509873 |
| 12 | MP0009840_abnormal_foam_cell | 2.47594158 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44980310 |
| 14 | MP0005220_abnormal_exocrine_pancreas | 2.24790770 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.10172752 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.04828512 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.03207290 |
| 18 | MP0003436_decreased_susceptibility_to | 1.93897890 |
| 19 | MP0005451_abnormal_body_composition | 1.90280408 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.87375280 |
| 21 | MP0003091_abnormal_cell_migration | 1.80379549 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.68596669 |
| 23 | MP0004858_abnormal_nervous_system | 1.67677237 |
| 24 | MP0005332_abnormal_amino_acid | 1.64854927 |
| 25 | MP0000609_abnormal_liver_physiology | 1.64191718 |
| 26 | MP0003186_abnormal_redox_activity | 1.60126227 |
| 27 | MP0006054_spinal_hemorrhage | 1.59227139 |
| 28 | MP0003868_abnormal_feces_composition | 1.59089271 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.55449182 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.51429970 |
| 31 | MP0005503_abnormal_tendon_morphology | 1.50086901 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.49831179 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.48509350 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.46831322 |
| 35 | MP0005623_abnormal_meninges_morphology | 1.46823225 |
| 36 | MP0005275_abnormal_skin_tensile | 1.46079455 |
| 37 | MP0003724_increased_susceptibility_to | 1.42321384 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.42123980 |
| 39 | MP0001849_ear_inflammation | 1.41162814 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.40811149 |
| 41 | MP0005165_increased_susceptibility_to | 1.38410955 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.37247494 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.36946352 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.30020253 |
| 45 | MP0002933_joint_inflammation | 1.29689571 |
| 46 | MP0002693_abnormal_pancreas_physiology | 1.29490406 |
| 47 | MP0001944_abnormal_pancreas_morphology | 1.26973344 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.26586105 |
| 49 | MP0008260_abnormal_autophagy | 1.25097673 |
| 50 | MP0000685_abnormal_immune_system | 1.24050907 |
| 51 | MP0008469_abnormal_protein_level | 1.22829514 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.22566600 |
| 53 | MP0009785_altered_susceptibility_to | 1.22062782 |
| 54 | MP0000767_abnormal_smooth_muscle | 1.15152964 |
| 55 | MP0003075_altered_response_to | 1.14971320 |
| 56 | MP0005508_abnormal_skeleton_morphology | 1.14352531 |
| 57 | MP0000598_abnormal_liver_morphology | 1.14053632 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.13910837 |
| 59 | MP0002419_abnormal_innate_immunity | 1.12513326 |
| 60 | MP0001764_abnormal_homeostasis | 1.11266404 |
| 61 | MP0002060_abnormal_skin_morphology | 1.09981283 |
| 62 | MP0005164_abnormal_response_to | 1.09957568 |
| 63 | MP0000343_altered_response_to | 1.09249012 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.08548038 |
| 65 | MP0005023_abnormal_wound_healing | 1.08267036 |
| 66 | MP0001542_abnormal_bone_strength | 1.07896118 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.07548429 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.07223743 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.04855948 |
| 70 | MP0003279_aneurysm | 1.04708451 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.04323283 |
| 72 | MP0009764_decreased_sensitivity_to | 1.02445109 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 1.02404978 |
| 74 | MP0005025_abnormal_response_to | 1.01962760 |
| 75 | MP0005501_abnormal_skin_physiology | 1.01285711 |
| 76 | MP0009053_abnormal_anal_canal | 1.00501114 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.99269895 |
| 78 | MP0000678_abnormal_parathyroid_gland | 0.98626904 |
| 79 | MP0008004_abnormal_stomach_pH | 0.98443416 |
| 80 | MP0001243_abnormal_dermal_layer | 0.98015287 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 0.97278357 |
| 82 | MP0009763_increased_sensitivity_to | 0.96816970 |
| 83 | MP0000858_altered_metastatic_potential | 0.95994730 |
| 84 | MP0009384_cardiac_valve_regurgitation | 0.95390390 |
| 85 | MP0000751_myopathy | 0.95114205 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.93709875 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93556138 |
| 88 | MP0003795_abnormal_bone_structure | 0.93164129 |
| 89 | MP0004233_abnormal_muscle_weight | 0.92313382 |
| 90 | MP0005408_hypopigmentation | 0.91933712 |
| 91 | MP0002796_impaired_skin_barrier | 0.91799675 |
| 92 | MP0001790_abnormal_immune_system | 0.91463678 |
| 93 | MP0005387_immune_system_phenotype | 0.91463678 |
| 94 | MP0005000_abnormal_immune_tolerance | 0.91217148 |
| 95 | MP0004947_skin_inflammation | 0.90062970 |
| 96 | MP0004510_myositis | 0.90035920 |
| 97 | MP0002078_abnormal_glucose_homeostasis | 0.89669427 |
| 98 | MP0005390_skeleton_phenotype | 0.89448063 |
| 99 | MP0002896_abnormal_bone_mineralization | 0.88934202 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.88073594 |
| 101 | MP0000681_abnormal_thyroid_gland | 0.87971035 |
| 102 | MP0003448_altered_tumor_morphology | 0.86493181 |
| 103 | MP0006082_CNS_inflammation | 0.86446352 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.86423188 |
| 105 | MP0000534_abnormal_ureter_morphology | 0.84544289 |
| 106 | MP0001756_abnormal_urination | 0.82576588 |
| 107 | MP0005621_abnormal_cell_physiology | 0.82436051 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.82249145 |
| 109 | MP0010155_abnormal_intestine_physiology | 0.82199104 |
| 110 | MP0002928_abnormal_bile_duct | 0.81564454 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.80770197 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.80686416 |
| 113 | MP0001853_heart_inflammation | 0.79800841 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.79712974 |
| 115 | MP0009333_abnormal_splenocyte_physiolog | 0.78746287 |
| 116 | MP0001915_intracranial_hemorrhage | 0.78638945 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.78502480 |
| 118 | MP0009278_abnormal_bone_marrow | 0.78215428 |
| 119 | MP0003959_abnormal_lean_body | 0.78062125 |
| 120 | MP0000490_abnormal_crypts_of | 0.76340119 |
| 121 | MP0000249_abnormal_blood_vessel | 0.75926456 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.75017933 |
| 123 | MP0005670_abnormal_white_adipose | 0.74211756 |
| 124 | MP0002405_respiratory_system_inflammati | 0.72825564 |
| 125 | MP0002452_abnormal_antigen_presenting | 0.72551863 |
| 126 | MP0003123_paternal_imprinting | 0.72307270 |
| 127 | MP0002723_abnormal_immune_serum | 0.72235458 |
| 128 | MP0000462_abnormal_digestive_system | 0.71153663 |
| 129 | MP0003172_abnormal_lysosome_physiology | 0.70862550 |
| 130 | MP0000733_abnormal_muscle_development | 0.70402925 |
| 131 | MP0001216_abnormal_epidermal_layer | 0.70376614 |
| 132 | MP0003942_abnormal_urinary_system | 0.69818200 |
| 133 | MP0000627_abnormal_mammary_gland | 0.68650034 |
| 134 | MP0001800_abnormal_humoral_immune | 0.68574595 |
| 135 | MP0005671_abnormal_response_to | 0.68346324 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.67780495 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.67701308 |
| 138 | MP0009697_abnormal_copulation | 0.66641279 |
| 139 | MP0001881_abnormal_mammary_gland | 0.66570016 |
| 140 | MP0001614_abnormal_blood_vessel | 0.66435798 |
| 141 | MP0005375_adipose_tissue_phenotype | 0.66414124 |
| 142 | MP0002113_abnormal_skeleton_development | 0.65952470 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.65116342 |
| 144 | MP0005257_abnormal_intraocular_pressure | 0.64920337 |
| 145 | MP0001348_abnormal_lacrimal_gland | 0.64558848 |
| 146 | MP0001958_emphysema | 0.64109101 |
| 147 | MP0005197_abnormal_uvea_morphology | 0.64087883 |
| 148 | MP0002089_abnormal_postnatal_growth/wei | 0.63095653 |
| 149 | MP0009931_abnormal_skin_appearance | 0.62462542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.99491626 |
| 2 | Hypoglycemic coma (HP:0001325) | 4.25785161 |
| 3 | Abnormality of the intrinsic pathway (HP:0010989) | 3.96934732 |
| 4 | Deep venous thrombosis (HP:0002625) | 3.95333475 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 3.92312911 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.88390887 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.83835379 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 3.83747301 |
| 9 | Xanthomatosis (HP:0000991) | 3.78796674 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 3.21733221 |
| 11 | Aortic dissection (HP:0002647) | 3.21324884 |
| 12 | Ankle contracture (HP:0006466) | 3.15689924 |
| 13 | Beaking of vertebral bodies (HP:0004568) | 3.15174877 |
| 14 | Hypoglycemic seizures (HP:0002173) | 3.11165593 |
| 15 | Fat malabsorption (HP:0002630) | 3.08427256 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.07528411 |
| 17 | Protrusio acetabuli (HP:0003179) | 3.06607152 |
| 18 | Joint hemorrhage (HP:0005261) | 2.97365195 |
| 19 | Achilles tendon contracture (HP:0001771) | 2.94710042 |
| 20 | Spinal rigidity (HP:0003306) | 2.94424791 |
| 21 | Complement deficiency (HP:0004431) | 2.91754282 |
| 22 | Abnormality of the Achilles tendon (HP:0005109) | 2.89516886 |
| 23 | Generalized aminoaciduria (HP:0002909) | 2.84145500 |
| 24 | Vascular tortuosity (HP:0004948) | 2.81883859 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 2.81255838 |
| 26 | Fragile skin (HP:0001030) | 2.79069785 |
| 27 | Blue sclerae (HP:0000592) | 2.77863330 |
| 28 | Ketosis (HP:0001946) | 2.76812178 |
| 29 | Wormian bones (HP:0002645) | 2.76350823 |
| 30 | Short nail (HP:0001799) | 2.76202339 |
| 31 | Osteolytic defects of the hand bones (HP:0009699) | 2.74747765 |
| 32 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.74747765 |
| 33 | Atrophic scars (HP:0001075) | 2.73323140 |
| 34 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.72888504 |
| 35 | Myocardial infarction (HP:0001658) | 2.72513681 |
| 36 | Abnormality of dentin (HP:0010299) | 2.72385592 |
| 37 | Cervical subluxation (HP:0003308) | 2.72179685 |
| 38 | Bladder diverticulum (HP:0000015) | 2.71855879 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.68766009 |
| 40 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68766009 |
| 41 | Distal upper limb amyotrophy (HP:0007149) | 2.68540243 |
| 42 | Upper limb amyotrophy (HP:0009129) | 2.68540243 |
| 43 | Steatorrhea (HP:0002570) | 2.67547779 |
| 44 | Arterial tortuosity (HP:0005116) | 2.66971742 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.64013427 |
| 46 | Aortic aneurysm (HP:0004942) | 2.63823863 |
| 47 | Abnormal tarsal ossification (HP:0008369) | 2.60441614 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.59280505 |
| 49 | Hypolipoproteinemia (HP:0010981) | 2.56005567 |
| 50 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.54500046 |
| 51 | Symptomatic seizures (HP:0011145) | 2.53997314 |
| 52 | Abnormality of complement system (HP:0005339) | 2.52733742 |
| 53 | Follicular hyperkeratosis (HP:0007502) | 2.50137257 |
| 54 | Ketoacidosis (HP:0001993) | 2.49559164 |
| 55 | Elbow flexion contracture (HP:0002987) | 2.45366724 |
| 56 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44079608 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.43154328 |
| 58 | Peritonitis (HP:0002586) | 2.40880290 |
| 59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40874192 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40874192 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40874192 |
| 62 | Dilatation of the ascending aorta (HP:0005111) | 2.40800896 |
| 63 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.39790453 |
| 64 | Late onset (HP:0003584) | 2.39715856 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.38382781 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.37573637 |
| 67 | Protuberant abdomen (HP:0001538) | 2.36629164 |
| 68 | Hyperglycemia (HP:0003074) | 2.36104396 |
| 69 | Abnormality of the acetabulum (HP:0003170) | 2.35120268 |
| 70 | Hypoalphalipoproteinemia (HP:0003233) | 2.34871254 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33649266 |
| 72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.32831810 |
| 73 | Biconcave vertebral bodies (HP:0004586) | 2.32322606 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.32181794 |
| 75 | Hyperammonemia (HP:0001987) | 2.31604185 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.31536572 |
| 77 | Conjugated hyperbilirubinemia (HP:0002908) | 2.30597710 |
| 78 | Increased connective tissue (HP:0009025) | 2.29686006 |
| 79 | Nonimmune hydrops fetalis (HP:0001790) | 2.28413434 |
| 80 | Abnormal foot bone ossification (HP:0010675) | 2.27141835 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 2.26194676 |
| 82 | Hyperacusis (HP:0010780) | 2.26160760 |
| 83 | Spondylolisthesis (HP:0003302) | 2.25598466 |
| 84 | Distal lower limb muscle weakness (HP:0009053) | 2.25541400 |
| 85 | Hand muscle atrophy (HP:0009130) | 2.25103981 |
| 86 | Hyperbilirubinemia (HP:0002904) | 2.24683048 |
| 87 | Soft skin (HP:0000977) | 2.24322545 |
| 88 | Abnormal delivery (HP:0001787) | 2.23338794 |
| 89 | Generalized amyotrophy (HP:0003700) | 2.22806619 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.21761591 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 2.21521971 |
| 92 | J-shaped sella turcica (HP:0002680) | 2.21350692 |
| 93 | Abnormal cartilage morphology (HP:0002763) | 2.20706558 |
| 94 | Cerebral aneurysm (HP:0004944) | 2.19481546 |
| 95 | Abnormality of nucleobase metabolism (HP:0010932) | 2.15903489 |
| 96 | Abnormality of methionine metabolism (HP:0010901) | 2.14810587 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14320314 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14320314 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14320314 |
| 100 | Pancreatitis (HP:0001733) | 2.13629464 |
| 101 | Epiphyseal dysplasia (HP:0002656) | 2.12122844 |
| 102 | Cholecystitis (HP:0001082) | 2.11752607 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.11752607 |
| 104 | Slender build (HP:0001533) | 2.11459125 |
| 105 | Broad face (HP:0000283) | 2.09304981 |
| 106 | Amyloidosis (HP:0011034) | 2.08535965 |
| 107 | Epidermoid cyst (HP:0200040) | 2.08383669 |
| 108 | Genu recurvatum (HP:0002816) | 2.07390637 |
| 109 | Joint stiffness (HP:0001387) | 2.07306365 |
| 110 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.06919989 |
| 111 | Purpura (HP:0000979) | 2.06351989 |
| 112 | Gingival bleeding (HP:0000225) | 2.06313840 |
| 113 | Ulnar bowing (HP:0003031) | 2.05833725 |
| 114 | Disproportionate tall stature (HP:0001519) | 2.04451552 |
| 115 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.04277664 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.04187285 |
| 117 | Aneurysm (HP:0002617) | 2.02126772 |
| 118 | Thrombocytosis (HP:0001894) | 2.01313050 |
| 119 | Thoracolumbar scoliosis (HP:0002944) | 2.00427875 |
| 120 | Mitral stenosis (HP:0001718) | 2.00095517 |
| 121 | Hemorrhage of the eye (HP:0011885) | 1.99943545 |
| 122 | Joint laxity (HP:0001388) | 1.99869394 |
| 123 | Coxa vara (HP:0002812) | 1.99764285 |
| 124 | Skin nodule (HP:0200036) | 1.99001972 |
| 125 | Increased mean platelet volume (HP:0011877) | 1.96668277 |
| 126 | Petechiae (HP:0000967) | 1.95697703 |
| 127 | Abnormality of carpal bone ossification (HP:0006257) | 1.95368665 |
| 128 | Increased variability in muscle fiber diameter (HP:0003557) | 1.94711456 |
| 129 | Menorrhagia (HP:0000132) | 1.94130612 |
| 130 | Trismus (HP:0000211) | 1.93322757 |
| 131 | Hypercholesterolemia (HP:0003124) | 1.92334889 |
| 132 | Hyperparathyroidism (HP:0000843) | 1.92224730 |
| 133 | Mitral regurgitation (HP:0001653) | 1.91434830 |
| 134 | Hepatocellular carcinoma (HP:0001402) | 1.90844462 |
| 135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90640221 |
| 136 | Glomerulonephritis (HP:0000099) | 1.90077496 |
| 137 | Hyperextensible skin (HP:0000974) | 1.89656108 |
| 138 | Cupped ribs (HP:0000887) | 1.89299837 |
| 139 | Cardiovascular calcification (HP:0011915) | 1.88265844 |
| 140 | Gout (HP:0001997) | 1.87745633 |
| 141 | Insulin resistance (HP:0000855) | 1.87221297 |
| 142 | Elevated alkaline phosphatase (HP:0003155) | 1.87073461 |
| 143 | Ovoid vertebral bodies (HP:0003300) | 1.86050648 |
| 144 | Abdominal distention (HP:0003270) | 1.85471390 |
| 145 | Vascular calcification (HP:0004934) | 1.85069259 |
| 146 | Entropion (HP:0000621) | 1.84502598 |
| 147 | Impaired platelet aggregation (HP:0003540) | 1.83678836 |
| 148 | Abnormal platelet function (HP:0011869) | 1.83678836 |
| 149 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.83599351 |
| 150 | Dicarboxylic aciduria (HP:0003215) | 1.83599351 |
| 151 | Shallow orbits (HP:0000586) | 1.82494840 |
| 152 | Ectopia lentis (HP:0001083) | 1.81681863 |
| 153 | Abnormal platelet volume (HP:0011876) | 1.81140784 |
| 154 | Hyperglycinemia (HP:0002154) | 1.80932320 |
| 155 | Venous abnormality (HP:0002624) | 1.80798547 |
| 156 | Flat acetabular roof (HP:0003180) | 1.80709101 |
| 157 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80657945 |
| 158 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80569723 |
| 159 | Platyspondyly (HP:0000926) | 1.80353456 |
| 160 | Hydroxyprolinuria (HP:0003080) | 1.79879341 |
| 161 | Abnormality of proline metabolism (HP:0010907) | 1.79879341 |
| 162 | Eczematoid dermatitis (HP:0000976) | 1.78661795 |
| 163 | Thin bony cortex (HP:0002753) | 1.78302617 |
| 164 | Abnormal ossification of hand bones (HP:0005921) | 1.77977423 |
| 165 | Long toe (HP:0010511) | 1.77736374 |
| 166 | Nuclear cataract (HP:0100018) | 1.77166120 |
| 167 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76928627 |
| 168 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76928627 |
| 169 | Natal tooth (HP:0000695) | 1.76170486 |
| 170 | Back pain (HP:0003418) | 1.76141333 |
| 171 | Polycythemia (HP:0001901) | 1.75504072 |
| 172 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75414267 |
| 173 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.75097959 |
| 174 | Opisthotonus (HP:0002179) | 1.73291949 |
| 175 | Hyperglycinuria (HP:0003108) | 1.72491300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.29283726 |
| 2 | BCKDK | 3.72573936 |
| 3 | FLT3 | 2.94390220 |
| 4 | TRIB3 | 2.90144537 |
| 5 | TAOK3 | 2.62923271 |
| 6 | NME2 | 2.36339949 |
| 7 | PIM2 | 2.22110382 |
| 8 | IRAK3 | 2.21017264 |
| 9 | ICK | 2.17904012 |
| 10 | INSRR | 2.13753697 |
| 11 | SIK1 | 2.13323400 |
| 12 | MYLK | 2.11519737 |
| 13 | SMG1 | 2.09636927 |
| 14 | PIK3CG | 2.08872932 |
| 15 | LMTK2 | 2.03032022 |
| 16 | LIMK1 | 2.02892197 |
| 17 | PKN2 | 1.98623350 |
| 18 | PRPF4B | 1.96717245 |
| 19 | TBK1 | 1.92912629 |
| 20 | MAP3K3 | 1.89184194 |
| 21 | FGFR4 | 1.86205578 |
| 22 | ARAF | 1.85083356 |
| 23 | PASK | 1.79662878 |
| 24 | ZAP70 | 1.70973531 |
| 25 | MAP3K14 | 1.67413169 |
| 26 | EIF2AK3 | 1.61411090 |
| 27 | IRAK4 | 1.48820408 |
| 28 | JAK3 | 1.48326094 |
| 29 | TESK1 | 1.45794137 |
| 30 | TYK2 | 1.45326904 |
| 31 | RPS6KA4 | 1.44505615 |
| 32 | MAPK15 | 1.40159547 |
| 33 | PTK6 | 1.39098488 |
| 34 | FRK | 1.32421894 |
| 35 | MAP2K3 | 1.29659814 |
| 36 | NEK9 | 1.28758784 |
| 37 | EPHA3 | 1.26855621 |
| 38 | KDR | 1.24427633 |
| 39 | KIT | 1.18753926 |
| 40 | EPHB2 | 1.17743829 |
| 41 | SCYL2 | 1.13759559 |
| 42 | LRRK2 | 1.13399910 |
| 43 | PRKD2 | 1.12057898 |
| 44 | MAP4K1 | 1.10642479 |
| 45 | EPHA2 | 1.07128060 |
| 46 | MAPKAPK3 | 1.05031759 |
| 47 | MST1R | 1.02524149 |
| 48 | ILK | 1.02271060 |
| 49 | NTRK1 | 1.01460042 |
| 50 | MOS | 0.99655713 |
| 51 | TGFBR2 | 0.99611607 |
| 52 | IKBKB | 0.99192317 |
| 53 | JAK1 | 0.97693956 |
| 54 | VRK2 | 0.95969906 |
| 55 | MAP2K2 | 0.94574298 |
| 56 | BTK | 0.92874357 |
| 57 | TEC | 0.91176137 |
| 58 | IKBKE | 0.91027770 |
| 59 | TRPM7 | 0.87707110 |
| 60 | DYRK1B | 0.86767366 |
| 61 | PTK2 | 0.86727883 |
| 62 | DDR2 | 0.86332072 |
| 63 | BLK | 0.86098595 |
| 64 | ABL2 | 0.85995356 |
| 65 | STK38 | 0.85961003 |
| 66 | BRSK2 | 0.84660398 |
| 67 | EIF2AK1 | 0.83567491 |
| 68 | MAP3K10 | 0.83500561 |
| 69 | MAP3K8 | 0.83216246 |
| 70 | NLK | 0.82123716 |
| 71 | CHUK | 0.81928354 |
| 72 | PDGFRA | 0.80812216 |
| 73 | CDC42BPA | 0.79640288 |
| 74 | IRAK1 | 0.78643792 |
| 75 | CDK12 | 0.77940564 |
| 76 | ERBB4 | 0.77062754 |
| 77 | MAP3K11 | 0.76616416 |
| 78 | CSK | 0.76544288 |
| 79 | EEF2K | 0.74266718 |
| 80 | CDK8 | 0.73106963 |
| 81 | MAP3K12 | 0.73006143 |
| 82 | PRKG2 | 0.72832995 |
| 83 | STK38L | 0.71885762 |
| 84 | EPHB1 | 0.71638162 |
| 85 | CSF1R | 0.69788352 |
| 86 | PDPK1 | 0.68467747 |
| 87 | LATS1 | 0.68121539 |
| 88 | HIPK2 | 0.68119930 |
| 89 | RIPK1 | 0.67969203 |
| 90 | PTK2B | 0.67423943 |
| 91 | MET | 0.65665060 |
| 92 | JAK2 | 0.63383978 |
| 93 | TESK2 | 0.63377032 |
| 94 | KSR2 | 0.62766651 |
| 95 | STK3 | 0.61279465 |
| 96 | PIM1 | 0.61176165 |
| 97 | LATS2 | 0.61167587 |
| 98 | CDK7 | 0.60205206 |
| 99 | BRAF | 0.60202865 |
| 100 | PAK1 | 0.60050170 |
| 101 | * MTOR | 0.58639697 |
| 102 | MAPK11 | 0.58459464 |
| 103 | STK16 | 0.57714187 |
| 104 | PAK2 | 0.55413868 |
| 105 | TGFBR1 | 0.53691844 |
| 106 | NUAK1 | 0.52433070 |
| 107 | TAOK2 | 0.51590243 |
| 108 | RPS6KA2 | 0.50877098 |
| 109 | DAPK1 | 0.50718011 |
| 110 | ITK | 0.48189180 |
| 111 | BRSK1 | 0.48044418 |
| 112 | STK10 | 0.47938049 |
| 113 | DAPK3 | 0.47776850 |
| 114 | ROCK2 | 0.47430277 |
| 115 | ACVR1B | 0.45582971 |
| 116 | CDK6 | 0.45528821 |
| 117 | PAK4 | 0.45500516 |
| 118 | MAP3K1 | 0.45183045 |
| 119 | TAOK1 | 0.44853358 |
| 120 | CLK1 | 0.44375093 |
| 121 | SIK3 | 0.42481505 |
| 122 | CAMKK2 | 0.41532086 |
| 123 | LYN | 0.40647509 |
| 124 | DMPK | 0.39139899 |
| 125 | SYK | 0.38084842 |
| 126 | IGF1R | 0.37914941 |
| 127 | MAP3K13 | 0.37363308 |
| 128 | MAPKAPK2 | 0.36430003 |
| 129 | BMX | 0.36193681 |
| 130 | ERBB3 | 0.36099082 |
| 131 | TTN | 0.35825053 |
| 132 | GSK3A | 0.34832369 |
| 133 | STK24 | 0.33574714 |
| 134 | MAP3K2 | 0.33421552 |
| 135 | CDK9 | 0.33280827 |
| 136 | RPS6KB2 | 0.33209871 |
| 137 | FGFR3 | 0.32748370 |
| 138 | MAP2K1 | 0.32678760 |
| 139 | PIK3CA | 0.32165577 |
| 140 | ABL1 | 0.30758602 |
| 141 | TXK | 0.29412737 |
| 142 | IRAK2 | 0.29043550 |
| 143 | RET | 0.28200543 |
| 144 | SRC | 0.26979137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.49343822 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22199496 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.96186733 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.87709439 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29205654 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.28534458 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21900859 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.18370426 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.14598189 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.10759224 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00630390 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99980588 |
| 13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.97027632 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95206228 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.89589657 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.80907452 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79808355 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73975382 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.72778516 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70308418 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70063514 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66007092 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.64065263 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.62399570 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61829132 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.61740183 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.55865697 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55643109 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.53632266 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51805656 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49747110 |
| 32 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.45340784 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44633261 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43408224 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42678853 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40398274 |
| 37 | Thyroid cancer_Homo sapiens_hsa05216 | 1.34382632 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33478767 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.29201221 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28504441 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27727172 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25520933 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22258601 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19792288 |
| 45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19640948 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 1.19076900 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18898337 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18513008 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.16603157 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14894475 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13121774 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12941445 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11900317 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09371315 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08041303 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05180208 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04851510 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04621814 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 1.00720178 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00007097 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99762626 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97927374 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97825933 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97206895 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97120392 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.95596231 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.95542806 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94634547 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93796439 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93148779 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92461204 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.91958530 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88630458 |
| 74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88536757 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87796145 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87318591 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86768886 |
| 78 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83873002 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82031858 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.81137105 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79059954 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78712656 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78707694 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77997777 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76177219 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75385649 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.75094611 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73827159 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72597941 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72153951 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71009077 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70538382 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69641465 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68555373 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.67485087 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65996542 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64035288 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63721044 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.62080948 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.59103640 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57552155 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57148709 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56480610 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.56081442 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54346815 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.53025832 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51130931 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49941735 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.49701131 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49126241 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48492103 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47004588 |
| 113 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.46878352 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.45553555 |
| 115 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44914606 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.44726511 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44231884 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43949102 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.42505454 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.42088604 |
| 121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42048667 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.41508924 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.40411644 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40303506 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40112389 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39762092 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39160238 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37901279 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37215310 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37116487 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36825318 |
| 132 | Measles_Homo sapiens_hsa05162 | 0.34361559 |
| 133 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34043338 |
| 134 | Apoptosis_Homo sapiens_hsa04210 | 0.32592991 |
| 135 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.31941967 |
| 136 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31843264 |
| 137 | Proteasome_Homo sapiens_hsa03050 | 0.31174862 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.26808586 |
| 139 | Bladder cancer_Homo sapiens_hsa05219 | 0.25526367 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25503524 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24699824 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.23759835 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23568208 |
| 144 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23018584 |

